These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2829259)

  • 1. Naloxone has no effect on hormonal responses to ECT in man.
    Turner TH; Ur E; Grossman A
    Psychiatry Res; 1987 Nov; 22(3):207-12. PubMed ID: 2829259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone response to repeated electroconvulsive therapy: effects of naloxone.
    Haskett RF; Zis AP; Albala AA
    Biol Psychiatry; 1985 Jun; 20(6):623-33. PubMed ID: 2986737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone, prolactin and cortisol nyctohemeral variations during naloxone-induced opiate receptor blockade in man.
    Delitala G; Giusti M; Rodriguez G; Mazzocchi G; Ferrini S; Baccelliere L; Montano V; Rosadini G; Giordano G
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):321-6. PubMed ID: 6287782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid modulation of the effects of repeated stress on ACTH, cortisol, prolactin, and growth hormone in pigs.
    Rushen J; Schwarze N; Ladewig J; Foxcroft G
    Physiol Behav; 1993 May; 53(5):923-8. PubMed ID: 8390062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of an opiate antagonist on the hormonal changes induced by hexarelin.
    Korbonits M; Trainer PJ; Besser GM
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):365-71. PubMed ID: 7586608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of single and repeated electroconvulsive therapy sessions on plasma ACTH, prolactin, growth hormone and cortisol concentrations.
    Kronfol Z; Hamdan-Allen G; Goel K; Hill EM
    Psychoneuroendocrinology; 1991; 16(4):345-52. PubMed ID: 1660606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of acute and repeated electroconvulsive treatment on plasma beta-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients.
    Weizman A; Gil-Ad I; Grupper D; Tyano S; Laron Z
    Psychopharmacology (Berl); 1987; 93(1):122-6. PubMed ID: 2957720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome.
    Deakin JF; Ferrier IN; Crow TJ; Johnstone EC; Lawler P
    Br J Psychiatry; 1983 Dec; 143():618-24. PubMed ID: 6661605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naloxone on prolactin, growth hormone and cortisol response to insulin hypoglycemia in obese subjects.
    Papalia D; Lunetta M; Di Mauro M
    J Endocrinol Invest; 1989 Dec; 12(11):777-82. PubMed ID: 2693516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of stimulus intensity on prolactin and cortisol release induced by unilateral electroconvulsive therapy.
    Zis AP; Yatham LN; Lam RW; Clark CM; Srisurapanont M; McGarvey K
    Neuropsychopharmacology; 1996 Sep; 15(3):263-70. PubMed ID: 8873109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ECT on the neuroendocrine response to apomorphine in severely depressed patients.
    Christie JE; Whalley LJ; Brown NS; Dick H
    Br J Psychiatry; 1982 Mar; 140():268-73. PubMed ID: 6807386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the prolactin response induced by electroconvulsive therapy in schizophrenics.
    Arató M; Erdós A; Kurcz M; Vermes I; Fekete M
    Acta Psychiatr Scand; 1980 Mar; 61(3):239-44. PubMed ID: 7376927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of naloxone to influence plasma growth hormone, prolactin, and cortisol secretions induced by insulin hypoglycemia.
    Wakabayashi I; Demura R; Miki N; Ohmura E; Miyoshi H; Shizume K
    J Clin Endocrinol Metab; 1980 Mar; 50(3):597-9. PubMed ID: 6987258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate receptors and anterior pituitary hormone secretion in man. Effect of naloxone infusion.
    Delitala G; Devilla L; Arata L
    Acta Endocrinol (Copenh); 1981 Jun; 97(2):150-6. PubMed ID: 6263025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective effects of ECT on hypothalamic-pituitary activity.
    Whalley LJ; Eagles JM; Bowler GM; Bennie JG; Dick HR; McGuire RJ; Fink G
    Psychol Med; 1987 May; 17(2):319-28. PubMed ID: 3037582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin reduces exercise-induced ACTH and cortisol rise in man.
    Coiro V; Passeri M; Davoli C; Bacchi-Modena A; Bianconi L; Volpi R; Chiodera P
    Acta Endocrinol (Copenh); 1988 Nov; 119(3):405-12. PubMed ID: 2847472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone increases the response of growth hormone and prolactin to stimuli in obese humans.
    Plewe G; Schneider U; Krause U; Beyer J
    J Endocrinol Invest; 1987 Apr; 10(2):137-41. PubMed ID: 3035002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of modulation of pituitary hormone stress response by neural pathways involving opiate receptors.
    Spiler IJ; Molitch ME
    J Clin Endocrinol Metab; 1980 Mar; 50(3):516-20. PubMed ID: 6244322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone pattern and post-treatment attitudes in patients with major depressive disorder given electroconvulsive therapy.
    Apéria B
    Acta Psychiatr Scand; 1986 Mar; 73(3):271-4. PubMed ID: 3012951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.